Gemcitabine for relapsed or resistant lymphoma.
Savage DG, Rule SA, Tighe M, Garrett TJ, Oster MW, Lee RT, Ruiz J, Heitjan D, Keohan ML, Flamm M, Johnson SA.
Savage DG, et al. Among authors: tighe m.
Ann Oncol. 2000 May;11(5):595-7. doi: 10.1023/a:1008307528519.
Ann Oncol. 2000.
PMID: 10907954
Free article.
Clinical Trial.